Leading Innovations in the HLA Typing Market
The current HLA Market Technology is also being leveraged by pharmaceutical giants to develop personalized neoantigen vaccines. Companies like Moderna and BioNTech are utilizing Next-Generation Sequencing (NGS) to map a patient’s unique HLA profile, ensuring that the custom-made vaccine
